Suchergebnisse - "Grunwald, Juan E"

Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials von Jaffe, Glenn J, Ying, Gui-Shuang, Toth, Cynthia A, Daniel, Ebenezer, Grunwald, Juan E, Martin, Daniel F, Maguire, Maureen G

“… To evaluate associations of morphologic features with 5-year visual acuity (VA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) …”
Weitere Angaben

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials von Sharma, Sumit, Toth, Cynthia A, Daniel, Ebenezer, Grunwald, Juan E, Maguire, Maureen G, Ying, Gui-Shuang, Huang, Jiayan, Martin, Daniel F, Jaffe, Glenn J

“… To describe the association between morphologic features on fundus photography (FP), fluorescein angiography (FA), and optical coherence tomography (OCT) and …”
Weitere Angaben

Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials von Grunwald, Juan E, Pistilli, Maxwell, Ying, Gui-Shuang, Maguire, Maureen G, Daniel, Ebenezer, Martin, Daniel F

“… To evaluate the growth of geographic atrophy (GA) during anti-vascular endothelial growth factor (VEGF) therapy. Cohort within a clinical trial. Patients …”
Weitere Angaben

Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials von Grunwald, Juan E, Daniel, Ebenezer, Huang, Jiayan, Ying, Gui-Shuang, Maguire, Maureen G, Toth, Cynthia A, Jaffe, Glenn J, Fine, Stuart L, Blodi, Barbara, Klein, Michael L, Martin, Alison A, Hagstrom, Stephanie A, Martin, Daniel F

“… To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Cohort within a randomized …”
Weitere Angaben

Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials von Grunwald, Juan E, Pistilli, Maxwell, Daniel, Ebenezer, Ying, Gui-Shuang, Pan, Wei, Jaffe, Glenn J, Toth, Cynthia A, Hagstrom, Stephanie A, Maguire, Maureen G, Martin, Daniel F

“… To estimate the incidence, size, and growth rate of geographic atrophy (GA) during 5 years of follow-up among participants in the Comparison of Age-Related …”
Weitere Angaben

Risk of scar in the comparison of age-related macular degeneration treatments trials von Daniel, Ebenezer, Toth, Cynthia A, Grunwald, Juan E, Jaffe, Glenn J, Martin, Daniel F, Fine, Stuart L, Huang, Jiayan, Ying, Gui-shuang, Hagstrom, Stephanie A, Winter, Katrina, Maguire, Maureen G

“… To describe risk factors for scar in eyes treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). Prospective cohort …”
Weitere Angaben

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials von Jaffe, Glenn J, Martin, Daniel F, Toth, Cynthia A, Daniel, Ebenezer, Maguire, Maureen G, Ying, Gui-Shuang, Grunwald, Juan E, Huang, Jiayan

“… To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with visual …”
Weitere Angaben

Fibroblast growth factor-23 and cardiovascular events in CKD von Scialla, Julia J, Xie, Huiliang, Rahman, Mahboob, Anderson, Amanda Hyre, Isakova, Tamara, Ojo, Akinlolu, Zhang, Xiaoming, Nessel, Lisa, Hamano, Takayuki, Grunwald, Juan E, Raj, Dominic S, Yang, Wei, He, Jiang, Lash, James P, Go, Alan S, Kusek, John W, Feldman, Harold, Wolf, Myles

“… An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abnormality of mineral metabolism in CKD. High FGF-23 levels promote left ventricular …”
Weitere Angaben

Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials von Zhou, Qiang, Daniel, Ebenezer, Maguire, Maureen G, Grunwald, Juan E, Martin, E Revell, Martin, Daniel F, Ying, Gui-Shuang

“… To evaluate the association between pseudodrusen and incidence of late age-related macular degeneration (AMD) in fellow eyes of patients with unilateral …”
Weitere Angaben

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) von Daniel, Ebenezer, Shaffer, James, Ying, Gui-shuang, Grunwald, Juan E, Martin, Daniel F, Jaffe, Glenn J, Maguire, Maureen G

“… To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all other eyes …”
Weitere Angaben

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration von Ying, Gui-shuang, Huang, Jiayan, Maguire, Maureen G, Jaffe, Glenn J, Grunwald, Juan E, Toth, Cynthia, Daniel, Ebenezer, Klein, Michael, Pieramici, Dante, Wells, John, Martin, Daniel F

“… To determine the baseline predictors of visual acuity (VA) outcomes 1 year after treatment with ranibizumab or bevacizumab for neovascular age-related macular …”
Weitere Angaben

Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials von Ying, Gui-Shuang, Maguire, Maureen G, Daniel, Ebenezer, Grunwald, Juan E, Ahmed, Osama, Martin, Daniel F

“… To evaluate the association between use of antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in participants with neovascular …”
Weitere Angaben

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) von Ying, Gui-shuang, Maguire, Maureen G, Daniel, Ebenezer, Ferris, Frederick L, Jaffe, Glenn J, Grunwald, Juan E, Toth, Cynthia A, Huang, Jiayan, Martin, Daniel F

“… To evaluate the association of baseline characteristics and early visual acuity (VA) response with visual outcomes at years 1 or 2 in the Comparison of …”
Weitere Angaben

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials von Ciulla, Thomas A, Cuilla, Thomas A, Ying, Gui-Shuang, Maguire, Maureen G, Martin, Daniel F, Jaffe, Glenn J, Grunwald, Juan E, Daniel, Ebenezer, Toth, Cynthia A

“… To assess the association of the vitreomacular interface with outcomes of eyes treated with anti-vascular endothelial growth factor drugs for neovascular …”
Weitere Angaben

Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials von Ying, Gui-shuang, Kim, Benjamin J, Maguire, Maureen G, Huang, Jiayan, Daniel, Ebenezer, Jaffe, Glenn J, Grunwald, Juan E, Blinder, Kevin J, Flaxel, Christina J, Rahhal, Firas, Regillo, Carl, Martin, Daniel F

“… Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of …”
Weitere Angaben

Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials von Maguire, Maureen G, Daniel, Ebenezer, Shah, Ankoor R, Grunwald, Juan E, Hagstrom, Stephanie A, Avery, Robert L, Huang, Jiayan, Martin, Revell W, Roth, Daniel B, Castellarin, Alessandro A, Bakri, Sophie J, Fine, Stuart L, Martin, Daniel F

“… To assess the influence of drug; dosing regimen; and traditional, nontraditional, and genetic risk factors on the incidence of choroidal neovascularization …”
Weitere Angaben

Systemic Medication Use and the Incidence and Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) von Delu, Song, Peiying, Hua, Brian L, VanderBeek, Joshua L, Dunaief, Juan E, Grunwald, Ebenezer, Daniel, Maureen G, Maguire, Daniel F, Martin, Gui-Shuang, Ying

“… To determine associations of systemic medications with the incidence and growth of geographic atrophy (GA) in participants of the Comparison of Age-related …”
Weitere Angaben

Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials von Daniel, Ebenezer, Ying, Gui-Shuang, Kim, Benjamin J, Toth, Cynthia A, Ferris, 3rd, Frederick, Martin, Daniel F, Grunwald, Juan E, Jaffe, Glenn J, Dunaief, Joshua L, Pan, Wei, Maguire, Maureen G

“… To describe changes in visual acuity (VA) and macular morphologic features at 5 years in eyes with nonfibrotic scar (NFS) identified at 1 year in the …”
Weitere Angaben

Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration von Metelitsina, Tatyana I, Grunwald, Juan E, DuPont, Joan C, Ying, Gui-Shuang, Brucker, Alexander J, Dunaief, Joshua L

“… To investigate in a longitudinal study whether foveolar choroidal blood flow changes are associated with the development of choroidal neovascularization (CNV) …”
Weitere Angaben

Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials von Grunwald, Juan E, Daniel, Ebenezer, Ying, Gui-Shuang, Pistilli, Maxwell, Maguire, Maureen G, Alexander, Judith, Whittock-Martin, Revell, Parker, Candace R, Sepielli, Krista, Blodi, Barbara A, Martin, Daniel F

“… To describe the methods used for assessment of baseline fundus characteristics from color photography and fluorescein angiography (FA) in the Comparison of …”
Weitere Angaben